Ausgabe 5/1997
Inhalt (14 Artikel)
Combined intravenous and oral mesna in outpatients treated with ifosfamide
Marshall P. Goren, Linda M. McKenna, Thomas L. Goodman
Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion
L. D. Nord, R. L. Stolfi, A. A. Alfieri, G. Netto, V. Reuter, S. S. Sternberg, J. R. Colofiore, J. A. Koutcher, D. S. Martin
Potentiation of cisplatin and carboplatin cytotoxicity by amphotericin B in different human ovarian carcinoma and malignant peritoneal mesothelioma cells
Laurent Poulain, François Sichel, Hubert Crouet, François Bureau, Pascal Gauduchon, Marc Gignoux, Jean-Yves Le Talaër
Urinary stability of carboxycyclophosphamide and carboxyifosfamide, two major metabolites of the anticancer drugs cyclophosphamide and ifosfamide
Claire Joqueviel, Véronique Gilard, Robert Martino, Myriam Malet-Martino, Ulf Niemeyer
Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines
E. H. Herman, J. Zhang, B. B. Hasinoff, D. P. Chadwick, J. R. Clark Jr., V. J. Ferrans
Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft
C. Bradley Hare, Gertrude B. Elion, O. Michael Colvin, Francis Ali-Osman, Owen W. Griffith, William P. Petros, Stephen Keir, Susan L. Marcelli, Darell D. Bigner, Henry S. Friedman
Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer
Vincent A. Miller, James R. Rigas, William P. Tong, Janice R. Reid, Katherine M. W. Pisters, Stefan C. Grant, Robert T. Heelan, Mark G. Kris
Pharmacokinetics of doxorubicin and epirubicin in mice during chlorpromazine-induced hypothermia
L. Lundgren-Eriksson, A. Carlsson, S. Eksborg, W. Ryd, R. Vesanen, R. Hultborn
A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene
Fumihiko Narasaki, Mikio Oka, Minoru Fukuda, Reiji Nakano, Koki Ikeda, Hiroshi Takatani, Kenji Terashi, Hiroshi Soda, Osamu Yano, Tsuyoshi Nakamura, L. Austin Doyle, Takashi Tsuruo, Shigeru Kohno
Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines
Yuko Hoki, Akira Fujimori, Yves Pommier
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity
Steinar Aamdal, Uta Bruntsch, Jean Kerger, Jaap Verweij, Wim Bokkel Huinink, Jantien Wanders, Ram Rastogi, Hillary R. Franklin, Stan B. Kaye
Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administration
P. G. Lindnér, Dennis Heath, Stephen B. Howell, Peter L. Naredi, Larsolof R. Hafström
Salivary drug monitoring of irinotecan and its active metabolite in cancer patients
Toshiaki Takahashi, Y. Fujiwara, Hidetaka Sumiyoshi, Takeshi Isobe, Naoki Yamaoka, Michio Yamakido
An N-myristoylated protein kinase C-α pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate
Philip J. Bergman, Karen R. Gravitt, C. A. O’Brian